Plastic and Reconstructive SurgeryGreenberg BM, Masem M, May JW Jr. Therapeutic value of intra- venous heparin in microvascular surgery: an experimental vascu- lar thrombosis study. Plast Reconstr Surg 1988;82(3):463-472Greenberg BM, Masem M, May JW.Therapeutic value of intravenous heparin in ...
The commonly used ratio of 1.5 to 2.5 times the normal control value is appropriate for some reagents, but for the other reagents a higher or lower range is appropriate. A suitable aPTT reagent for heparin control should be sensitive both to a threshold effect of heparin and to increasing ...
To ensure continuous anticoagulation when converting from Heparin Sodium Injection, USP to warfarin, continue full heparin therapy for several days until the INR (prothrombin time) has reached a stable therapeutic range. Heparin therapy may then be discontinued without tapering [see Drug Interactions (...
To ensure continuous anticoagulation when converting from Heparin Sodium to warfarin, continue full heparin therapy for several days until the INR (prothrombin time) has reached a stable therapeutic range. Heparin therapy may then be discontinued without tapering [seeDRUG INTERACTIONS]. Converting To Ora...
Establishing a Therapeutic Range for Heparin Therapy ratios of 1.5 to 2.5 times the control value as compared with a therapeutic range determined by protamine titration heparin levels of 0.2 to 0.4 U/mL... Brill-Edwards,Patrick - 《Annals of Internal Medicine》 被引量: 769发表: 1993年 The...
Concentrations range from 1000 to 40,000 units/mlGiven SQ or IV (never IM) Dosage Prophylaxis of Thromboembolism SQ(adult): 5000 units q 8-12 hrs.Heparin sodium for use in heparin locks is dispensed in diluted solutions, preloaded syringes and is not used for SQ injections. Objective of ...
Generic name f,b,eMW (Da) average/rangeaAnti Xa/IIa ratiocSulfate/carboxyl ratiofRelative potency: Concentrations of each LMWH (anti Xa IU/ml) Needed to:Preparation Decrease by 50% thrombin generationDouble the lag time preceding thrombin generationPreparation methoddTreatment/Major reagent employed...
Brill-Edwards P, Ginsberg JS, Johnston M, Hirsh J (1993) Establishing a therapeutic range for heparin therapy. Ann Intern Med 119:104–109 PubMedCASGoogle Scholar Brinkhous KM, Smith HP, Warner ED, Seegers WH (1939) The inhibition of blood clotting: an unidentified substance which acts in...
To ensure continuous anticoagulation when converting from heparin sodium to warfarin, continue full heparin therapy for several days until the INR (prothrombin time) has reached a stable therapeutic range. Heparin therapy may then be discontinued without tapering [see Drug Interactions (7.1)]. 2.7 Con...
The oligosaccharides dp14 (filled), dp12 (open), dp10 (hashed) and dp8 (dots) were then (B) used at a range of concentrations to compete CXCL12 from heparin. Finally (C), the dp14, dp12 and dp10 oligosaccharides were competed against a heparan sulphate solid-phase for CXCL12 binding ...